List of Biotech, Pharmaceutical & Life Sciences companies in Turkey - 8

Bioeksen R&D Technologies is a biotechnology company established with the aim of developing and producing molecular diagnostic products for human health, animal health, food and water safety using Reverse Transcription and Real-Time Polymerase Chain Reaction (qPCR and RT-qPCR) technologies. It was founded in 2014 and received R&D Innovation support from KOSGEB. Since its establishment, Bioeksen has completed 32 different R&D projects and produced 180 different molecular biotechnology products as a result of these projects. Bioeksen operates ISO 13485 and ISO 9001 quality management systems and has two production facilities in Istanbul and Hannover (Germany) with Class 7 Clean Room infrastructure, providing a daily production capacity of 2 million tests. Among the 580 biotechnology companies in the world producing molecular diagnostic kits, Bioeksen is one of the first 5% of firms to have approval from the World Health Organization and the US Food and Drug Administration (FDA). Its product portfolio includes products developed to detect pathogens in samples from food, water, animals, and humans quickly and reliably, while also creating less waste with sustainable environmental awareness. Bioeksen has sold its products in 85 countries as 200 million tests. Bioeksen R&D Technologies Inc. successfully passes external quality control processes recognized worldwide, such as QCMD and Neqas. The company is working diligently with dedication to contribute to world health with its innovative, fast, and reliable systems.

CROTURK is a full service Turkish Contract Research Organization, established in Turkey as an enterprise for the management of the multinational clinical trials. We provide all services in CRO business, including regulatory affairs, study monitoring, medical writing, data management, staffing solutions and eCRF designs.

Inpharmus, formerly known as TRPharm, is a pharmaceutical company established in 2013 that focuses on innovative treatments for emerging markets. With a presence in nearly 20 countries and operations in 12, Inpharmus has offices in Istanbul and Dubai, serving as a significant player in the healthcare sector across the Middle East, Turkey, Africa, Russia, and the CIS region. The company offers a variety of services aimed at improving patient outcomes, including clinical research management, scientific study recovery, and early access programs for innovative treatments. Inpharmus develops, manufactures, and distributes therapies across multiple therapeutic areas to address unmet medical needs. The company collaborates with global partners, such as Fennec Pharmaceuticals, to enhance its reach and impact in emerging markets. Inpharmus is committed to bridging the gap between diagnosis and treatment, ensuring that patients receive effective care.

PhiTech Bioinformatics translates genome-wide molecular data (Genomics, Transcriptomics, Epigenomics, Microbiomics, etc.) into biotechnology solutions primarily for use in precision medicine. We are moving beyond genomics by applying cutting-edge algorithms to extract information critical for diagnostic decision making. We are currently focusing on development of RNA-based diagnostics. Follow us on Twitter @PhiTech_Bioinfo

RS Research is a clinical-stage biotechnology start-up based in Epalinges, Switzerland, with an additional location in Istanbul, Turkey. Founded in 2015, the company specializes in discovering and developing smart nanomedicines aimed at targeted cancer therapy. The company provides services for pre-clinical studies, utilizing its expertise in innovative drug delivery platforms to support the development of nanomedicines. RS Research's product pipeline includes smart nanomedicines like Sagitta® and Dui, which enhance the therapeutic index and manufacturability of treatments, and RS-0139, a drug candidate currently in Phase I clinical trials that targets tumors with specific receptors. RS Research is committed to advancing its technologies through research and development, as evidenced by its presentations at international conferences. The leadership team includes Co-Founder and Chief Scientific Officer Rana Sanyal and Co-Founder and Chief Operating Officer Sena Nomak.

TrioGrup is an expert full service CRO located in Turkey that can immediately bring years of consultative experience to bear upon your clinical trials program, from planning and initiation, through to execution and reporting. Trio Grup CRO also approved by Turkish regulatory authority MoH Contact: info@triogrup-cro.com You can send your CV with update photo to apply our appropriate positions to following adress: career@triogrup-cro.com

TRPHARM’s journey, which started in Turkey in 2013, continues with offices in Istanbul and Dubai. Currently, we deliver our products and services to approximately 20 countries, and we maintain our physical presence in 12 of these countries. We are growing rapidly with more than 100 employees who are competent in their fields. We combine our innovative business approaches with medical experience, with the experience of more than a hundred years of experience of the doctors and pharmacists in our team. Our journey that started with medicine continues with the inclusion of non-pharmaceutical health solutions. With our partners in various countries, we provide a wide range of services covering all areas from diagnosis to treatment. Our cooperation philosophy is based on transparency and coexistence within the framework of common goals, guided by our expertise. As TRPHARM, our mission that we have been loyal to since the first day is to bring together innovative solutions with health. Our vision, which we have created with our years of experience, is to be a global, innovative healthcare company. The values that we take as a guide in each of our steps are; LIFE We put people and nature at the heart of our relations with our colleagues, physicians, patients and all other stakeholders and aspire to build a sustainable ecosystem. COLLABORATION In all our actions and business activities, we put harmony, unity and efficiency at the center of our interactions and projects, both within our teams and with our stakeholders. BALANCE In all areas that we add value, we draw on broad vision and harmony of opposite poles/perspectives, and we observe balance and attentiveness in our actions. TRANSFORMATION We adapt to ever-changing conditions that life imposes on us all with resilience and courage. We foresee transformation and changes in needs, respond with agility and grasp new opportunities to achieve our leadership goal.

Turgut İlaçları A.Ş is one of the important entrepreneurial organizations of the Turkish industry with nearly 70 years of experience. Turgut İlaçları A.Ş. is a Turkish pharmaceutical company engaged in the development, production and commercialization of biotechnological drugs as well as the commercialization of high-tech small molecules. Turgut İlaçları was established as Fako İlaçları A.Ş. in 1959. was established and has been one of the leaders of the pharmaceutical industry in Turkey for nearly sixty years. In 2006, Turgut İlaçları A.Ş. The company, which was restructured under the name Turgut Biotechnology Group, started to invest in biotechnology in 2014. The main aim of our company in the field of biotechnology is to develop, produce and market high-quality biotechnology products for Turkey and the world market by creating a biotechnology infrastructure with international standards in Turkey. . Collaboration was made with the world's best service providers in the biotechnological production industry for the design of the facility and the supply of systems, equipment and materials. Turgut Gebze Biopharmaceutical Production Facility, whose construction started in 2016 by Turgut İlaçları to produce biopharmaceutical drugs, was established on an area of ​​15,157 m².